Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc.

NASDAQ:ALNY

Overview | Financials
Company Name Alnylam Pharmaceuticals, Inc.
Symbol ALNY
Currency USD
Price 276.33
Market Cap 35,475,521,730
Dividend Yield 0%
52-week-range 141.98 - 287.55
Industry Biotechnology
Sector Healthcare
CEO Dr. Yvonne L. Greenstreet M.B.A., MBA, MBChB
Website https://www.alnylam.com

An error occurred while fetching data.

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex

Related Stocks

Insulet Corporation logo

Insulet Corporation

PODD

237.68 USD

BioMarin Pharmaceutical Inc. logo

BioMarin Pharmaceutical Inc.

BMRN

71.41 USD

Viatris Inc. logo

Viatris Inc.

VTRS

11.9 USD

Bio-Techne Corporation logo

Bio-Techne Corporation

TECH

80.36 USD

Incyte Corporation logo

Incyte Corporation

INCY

66.82 USD

ICON Public Limited Company logo

ICON Public Limited Company

ICLR

300.92 USD

Financials

Numbers are in millions USD

Numbers are in millions USD